The Inner Circle acknowledges Robert Cable, CEO as an Inner Circle Lifetime
FAIRFAX STATION, Va., June 15, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Robert Cable, CEO is acknowledged as an Inner Circle Lifetime... Read more.
Breakthrough Immorta Bio Study Collaboration With TAM Global Increases Life Span In Mice over 70% Using Novel Combination Senolytics
NASHVILLE, Tenn., June 15, 2026 /PRNewswire/ — Immorta Bio President Thomas Ichim and TAM Global’s Chief Scientific Officer Francesco M. Marincola today... Read more.
Sopra Steria extends strategic collaboration with Red Hat to industrialise sovereign-ready embedded AI
PARIS, June 15, 2026 /PRNewswire/ — Sopra Steria today announced an extension of its strategic collaboration with Red Hat, the world’s leading provider... Read more.
Pardee Resources Company To Sell West Virginia Property
RADNOR, Pa., June 15, 2026 /PRNewswire/ — Pardee Resources Company (OTC: PDER) (the “Company”) announced today that it has entered into a definitive... Read more.
Responsible AI Institute Launches TrustX for Finance to Bring Verifiable Trust to Autonomous AI in Financial Services
New Autonomous Finance Initiative will help financial institutions classify, control, and verify autonomous AI systems before production deployment. AUSTIN, Texas... Read more.
New Cognizant Research Reveals $4.7 Trillion in Untapped AI Value Across G2000
Organizations that pair mature technology infrastructure with a fundamentals-first AI investment strategy outperform laggards by 31% on composite outcomes—and... Read more.
Securitas sets 2030 strategy with updated financial targets to accelerate earnings growth
STOCKHOLM, June 15, 2026 /PRNewswire/ — Securitas today presents its 2030 strategy together with updated financial targets, reinforcing its ambition to drive... Read more.
PAVS Announces Pricing of a $10 Million Registered Direct Offering of Class A Ordinary Shares and Pre-Funded Warrants
NEW YORK, June 15, 2026 /PRNewswire/ — PAVS (NASDAQ:PAVS) (the “Company”), a consumer products and digital commerce solutions company, today announced... Read more.
Hillhurst Bio Doses First Subject in Phase 2a Clinical Trial of HBI-002, a Novel Therapy for Parkinson’s Disease
SAN DIEGO, June 15, 2026 /PRNewswire/ — Hillhurst Biopharmaceuticals Inc. (“Hillhurst Bio”), a clinical-stage biopharmaceutical company focused... Read more.
AuguStar Life enhances its suite of living benefits
New feature gives clients flexible access to death benefit when they need it most CINCINNATI, June 15, 2026 /PRNewswire/ — AuguStar® Life, a Constellation... Read more.